Literature DB >> 7026332

Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) mice.

P R Flatt, C J Bailey.   

Abstract

To investigate the effect of the ob gene in the heterozygous condition, plasma glucose and insulin responses of adult heterozygous lean (ob/+) mice were compared with mice of the homozygous lean (+/+) and homozygous obese (ob/ob) genotypes. The ob/+ mice consumed 24% more food than +/+ mice although body weights were similar. Plasma glucose and insulin concentrations were respectively 16% and 176% higher in ob/+ mice than +/+ mice in the freely fed state, and 44% and 88% higher during glucose tolerance tests. In 24 hour fasted ob/+ mice, plasma glucose concentrations were 23% higher than +/+ mice but plasma insulin concentrations were not significantly different. Arginine produced a greater insulin response (172%) and a greater fall in glycaemia (200%) in ob/+ mice. A significant difference in the hypoglycaemic effect of insulin in ob/+ and +/+ mice was not observed. These results demonstrate an effect of the ob gene on glucose homeostasis in heterozygous lean (ob/+) mice. The abnormalities were qualitatively similar but considerably less severe than those in ob/ob mice, suggesting that ob/+ mice might prove useful to study factors predisposing to inappropriate hyperglycaemia.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7026332     DOI: 10.1007/bf00252768

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  21 in total

1.  Influence of the pituitary gland from the homozygote (+/+) and heterozygote (ob/+) lean mouse on insulin secretion in vitro.

Authors:  A Beloff-Chain; J Hawthorn; D Green
Journal:  FEBS Lett       Date:  1975-07-15       Impact factor: 4.124

2.  The genetics of litter size in mice.

Authors:  D S FALCONER
Journal:  J Cell Comp Physiol       Date:  1960-11

3.  The pituitary-adrenal system of the genetically obese (ob/ob) mouse.

Authors:  J A Edwardson; C A Hough
Journal:  J Endocrinol       Date:  1975-04       Impact factor: 4.286

4.  The influence of genetic background on the expression of the obese (Ob) gene in the mouse.

Authors:  D L Coleman; K P Hummel
Journal:  Diabetologia       Date:  1973-08       Impact factor: 10.122

Review 5.  Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays.

Authors:  D Rodbard
Journal:  Clin Chem       Date:  1974-10       Impact factor: 8.327

6.  Core temperature, O2 consumption, and early detection of ob-ob genotype in mice.

Authors:  M L Kaplan; G A Leveille
Journal:  Am J Physiol       Date:  1974-10

7.  Determination of glucose by an automatic analyser.

Authors:  J F Stevens
Journal:  Clin Chim Acta       Date:  1971-04       Impact factor: 3.786

8.  Glucagon antiserum: a tool to investigate the role of circulating glucagon in obese-hyperglycaemic (ob/ob) mice [proceedings].

Authors:  P R Flatt; S K Swanston-Flatt; C J Bailey
Journal:  Biochem Soc Trans       Date:  1979-10       Impact factor: 5.407

9.  Gastrointestinal apudosis in obese hyperglycaemic mice.

Authors:  J M Polak; A G Pearse; L Grimelius; V Marks
Journal:  Virchows Arch B Cell Pathol       Date:  1975-11-07

10.  Acute regulation of insulin release by the pituitary gland in relation to hyperinsulinaemia and obesity.

Authors:  A Beloff-Chain; S Bogdanovic; M A Cawthorne
Journal:  J Endocrinol       Date:  1979-06       Impact factor: 4.286

View more
  54 in total

1.  Development and functional characterization of insulin-releasing human pancreatic beta cell lines produced by electrofusion.

Authors:  Jane T McCluskey; Muhajir Hamid; Hong Guo-Parke; Neville H McClenaghan; Ramon Gomis; Peter R Flatt
Journal:  J Biol Chem       Date:  2011-04-22       Impact factor: 5.157

2.  Traditional plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice.

Authors:  S K Swanston-Flatt; C Day; C J Bailey; P R Flatt
Journal:  Diabetologia       Date:  1990-08       Impact factor: 10.122

3.  Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice.

Authors:  A M McKillop; B M Moran; Y H A Abdel-Wahab; P R Flatt
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

4.  Helodermin and islet hormone release in isolated rat pancreas.

Authors:  H C Fehmann; R Göke; B Göke; R Eissele; R Arnold
Journal:  Int J Pancreatol       Date:  1991-05

5.  Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice.

Authors:  N Irwin; P L McClean; F P M O'Harte; V A Gault; P Harriott; P R Flatt
Journal:  Diabetologia       Date:  2007-05-08       Impact factor: 10.122

6.  Sequential induction of beta cell rest and stimulation using stable GIP inhibitor and GLP-1 mimetic peptides improves metabolic control in C57BL/KsJ db/db mice.

Authors:  Varun Pathak; Srividya Vasu; Victor A Gault; Peter R Flatt; Nigel Irwin
Journal:  Diabetologia       Date:  2015-06-06       Impact factor: 10.122

7.  Beneficial effects of the novel cholecystokinin agonist (pGlu-Gln)-CCK-8 in mouse models of obesity/diabetes.

Authors:  N Irwin; P Frizelle; I A Montgomery; R C Moffett; F P M O'Harte; P R Flatt
Journal:  Diabetologia       Date:  2012-07-20       Impact factor: 10.122

8.  Double incretin receptor knock-out (DIRKO) mice present with alterations of trabecular and cortical micromorphology and bone strength.

Authors:  A Mieczkowska; S Mansur; B Bouvard; P R Flatt; B Thorens; N Irwin; D Chappard; G Mabilleau
Journal:  Osteoporos Int       Date:  2014-08-16       Impact factor: 4.507

9.  Streptozotocin-resistant BRIN-BD11 cells possess wide spectrum of toxin tolerance and enhanced insulin-secretory capacity.

Authors:  Hui-Kang Liu; Jane T McCluskey; Neville H McClenghan; Peter R Flatt
Journal:  Endocrine       Date:  2007-09-29       Impact factor: 3.633

10.  A novel DPP IV-resistant C-terminally extended glucagon analogue exhibits weight-lowering and diabetes-protective effects in high-fat-fed mice mediated through glucagon and GLP-1 receptor activation.

Authors:  Aisling M Lynch; Nupur Pathak; Varun Pathak; Finbarr P M O'Harte; Peter R Flatt; Nigel Irwin; Victor A Gault
Journal:  Diabetologia       Date:  2014-06-25       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.